5-Flurouracil disrupts nuclear export and nuclear pore permeability in a calcium dependent manner
Autor: | Karen K. Resendes, Sarah A Broskin, Lauren Foltz, Christina A Campbell, Audrey Nickle, Jarrett A Koper, Rebecca G. Anderson, Melissa M Bischak, Kelly J. Higby |
---|---|
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
Antimetabolites Antineoplastic Cancer Research Programmed cell death Clinical Biochemistry Active Transport Cell Nucleus Pharmaceutical Science Apoptosis Biology Irinotecan Permeability 03 medical and health sciences medicine Humans Drug Interactions Nuclear pore Nuclear export signal Egtazic Acid Cell Nucleus Pharmacology Biochemistry (medical) Cell Biology Neoplasm Proteins Cell biology ran GTP-Binding Protein 030104 developmental biology DNA Topoisomerases Type I Caspases Ran Nuclear Pore Cancer research Calcium Camptothecin Topotecan Fluorouracil Tumor Suppressor Protein p53 Nuclear transport HeLa Cells medicine.drug |
Zdroj: | Apoptosis. 22:393-405 |
ISSN: | 1573-675X 1360-8185 |
DOI: | 10.1007/s10495-016-1338-y |
Popis: | Regulation of nuclear transport is an essential component of apoptosis. As chemotherapy induced cell death progresses, nuclear transport and the nuclear pore complex (NPC) are slowly disrupted and dismantled. 5-Fluorouracil (5-FU) and the camptothecin derivatives irinotecan and topotecan, are linked to altered nuclear transport of specific proteins; however, their general effects on the NPC and transport during apoptosis have not been characterized. We demonstrate that 5-FU, but not topotecan, increases NPC permeability, and disrupts Ran-mediated nuclear transport before the disruption of the NPC. This increased permeability is dependent on increased cellular calcium, as the Ca2+ chelator BAPTA-AM, abolishes the effect. Furthermore, increased calcium alone was sufficient to disrupt the Ran gradient. Combination treatments of 5-FU with topotecan or irinotecan, similarly disrupted nuclear transport before disassembly of the NPC. In both single and combination treatments nuclear transport was disrupted before caspase 9 activation, indicating that 5-FU induces an early caspase-independent increase in NPC permeability and alteration of nuclear transport. Because Crm1-mediated nuclear export of tumor suppressors is linked to drug resistance we also examined the effect of 5-FU on the nuclear export of a specific target, topoisomerase. 5-FU treatment led to accumulation of topoisomerase in the nucleus and recovered the loss nuclear topoisomerase induced by irinotecan or topotecan, a known cause of drug resistance. Furthermore, 5-FU retains its ability to cause nuclear accumulation of p53 in the presence of irinotecan or topotecan. Our results reveal a new mechanism of action for these therapeutics during apoptosis, opening the door to other potential combination chemotherapies that employ 5-FU as a calcium mediated inhibitor of Crm1-induced nuclear export of tumor suppressors. |
Databáze: | OpenAIRE |
Externí odkaz: |